Limitations of employing antibody drug conjugates (ADCs) for targeting HIV infected cells as a strategy for hiv cure
Autor: | D. Gately, Don Graham, Daniel M. Gorman, Julie Strizki, E. Escandon, Y. Zheng, Y. Sun, L. Fayadat-Dilman, G. Wu, S. Bhowmik, Meiqing Lu, M. Breslin, N. Davis, Richard J. O. Barnard, R. Garbaccio, A. Manibusan |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2015 |
Předmět: |
Drug
biology Epidemiology business.industry media_common.quotation_subject Immunology Public Health Environmental and Occupational Health Human immunodeficiency virus (HIV) medicine.disease_cause Virology Microbiology QR1-502 Infectious Diseases Hiv infected medicine biology.protein Antibody Public aspects of medicine RA1-1270 business media_common Conjugate |
Zdroj: | Journal of Virus Eradication, Vol 1, Iss, Pp 39-(2015) |
ISSN: | 2055-6640 |
Databáze: | OpenAIRE |
Externí odkaz: |